Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00075439 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI) View Interleukin-12 in Treating Patients With Cancer in the Abdomen NCT00003046 Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center View Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer NCT00274885 Cancer
oxaliplatin
management of t...
18 Years - National Cancer Institute (NCI) View Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer NCT00005842 Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI) View Interleukin-12 in Treating Patients With Cancer in the Abdomen NCT00003046 Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center View Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors NCT00602082 Gastrointestina...
Islet Cell Tumo...
capecitabine
cisplatin
streptozocin
DNA analysis
RNA analysis
protein analysi...
proteomic profi...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer NCT00003427 Anal Cancer
Colorectal Canc...
Esophageal Canc...
Extrahepatic Bi...
Gallbladder Can...
Gastric Cancer
Gastrointestina...
Liver Cancer
Pancreatic Canc...
Small Intestine...
irinotecan hydr...
oxaliplatin
18 Years - Memorial Sloan Kettering Cancer Center View Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum NCT00005860 Cancer
floxuridine
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI) View Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer NCT00003439 Cancer
recombinant int...
18 Years - National Cancer Institute (NCI) View Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity NCT00003548 Cancer
aminocamptothec...
18 Years - NYU Langone Health View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery NCT00416767 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 Years Federation Francophone de Cancerologie Digestive View Irinotecan and Capecitabine in Treating Patients With Solid Tumors NCT00003867 Cancer
capecitabine
irinotecan hydr...
18 Years - 120 Years Montefiore Medical Center View Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors NCT00227617 Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
Neuroendocrine ...
bevacizumab
5-fluorouracil
leucovorin
oxaliplatin
18 Years - University of California, San Francisco View Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638 Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
thalidomide
- Memorial Sloan Kettering Cancer Center View Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773 Gastrointestina...
Islet Cell Carc...
octreotide acet...
vatalanib
anti-cytokine t...
antiangiogenesi...
biological ther...
endocrine thera...
enzyme inhibito...
growth factor a...
hormone therapy
protein tyrosin...
somatostatin an...
18 Years - 120 Years Eastern Cooperative Oncology Group View Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors NCT02259725 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
regorafenib
laboratory biom...
18 Years - University of Southern California View Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638 Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
thalidomide
- Memorial Sloan Kettering Cancer Center View Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California View Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer NCT00005842 Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI) View EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191 Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI) View Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma NCT00093782 Metastatic Gast...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
temsirolimus
laboratory biom...
18 Years - National Cancer Institute (NCI) View Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California View Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00075439 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI) View Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer NCT00397384 Adenocarcinoma ...
Adenocarcinoma ...
Advanced Adult ...
Carcinoma of th...
Gastrointestina...
Metastatic Gast...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Unresectable Ex...
Unresectable Ga...
cetuximab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer NCT00019474 Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Liver Cancer
Pancreatic Canc...
Small Intestine...
filgrastim
recombinant int...
fluorouracil
hydroxyurea
18 Years - 120 Years Montefiore Medical Center View Irinotecan and Capecitabine in Treating Patients With Solid Tumors NCT00003867 Cancer
capecitabine
irinotecan hydr...
18 Years - 120 Years Montefiore Medical Center View PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors NCT00017199 Gastrointestina...
Islet Cell Tumo...
bortezomib
18 Years - National Cancer Institute (NCI) View Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen NCT00016380 Cancer
dexamethasone
ondansetron
quality-of-life...
16 Years - 120 Years Canadian Cancer Trials Group View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors NCT00002470 Gastrointestina...
Lung Cancer
recombinant int...
fluorouracil
18 Years - National Cancer Institute (NCI) View Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors NCT00466856 Head and Neck C...
Islet Cell Tumo...
Metastatic Canc...
Pheochromocytom...
octreotide acet...
yttrium Y 90 re...
18 Years - Vanderbilt-Ingram Cancer Center View Interleukin-12 in Treating Patients With Cancer in the Abdomen NCT00003046 Anal Cancer
Colorectal Canc...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Recombinant Int...
18 Years - M.D. Anderson Cancer Center View Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00131911 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Neuroendocrine ...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
sorafenib tosyl...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery NCT00416767 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 Years Federation Francophone de Cancerologie Digestive View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer NCT00003439 Cancer
recombinant int...
18 Years - National Cancer Institute (NCI) View AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
AMG 706
octreotide
18 Years - Eastern Cooperative Oncology Group View AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
AMG 706
octreotide
18 Years - Eastern Cooperative Oncology Group View PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors NCT00017199 Gastrointestina...
Islet Cell Tumo...
bortezomib
18 Years - National Cancer Institute (NCI) View Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors NCT00002470 Gastrointestina...
Lung Cancer
recombinant int...
fluorouracil
18 Years - National Cancer Institute (NCI) View Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773 Gastrointestina...
Islet Cell Carc...
octreotide acet...
vatalanib
anti-cytokine t...
antiangiogenesi...
biological ther...
endocrine thera...
enzyme inhibito...
growth factor a...
hormone therapy
protein tyrosin...
somatostatin an...
18 Years - 120 Years Eastern Cooperative Oncology Group View Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors NCT02259725 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
regorafenib
laboratory biom...
18 Years - University of Southern California View EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers NCT05176665 Neoplasms
Neoplasm Metast...
Metastatic Gast...
EMB-01
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd. View Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer NCT00006368 Brain and Centr...
Breast Cancer
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Lymphoma
Melanoma (Skin)
Neoplastic Synd...
yttrium Y 90-ed...
18 Years - Novartis View Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors NCT00055809 Metastatic Gast...
Recurrent Gastr...
Regional Gastro...
PEG-interferon ...
bevacizumab
laboratory biom...
18 Years - National Cancer Institute (NCI) View Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors NCT00084461 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Regional Gastro...
Somatostatinoma
romidepsin
laboratory biom...
18 Years - National Cancer Institute (NCI) View Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients NCT00253383 Cancer
counseling inte...
educational int...
psychosocial as...
quality-of-life...
18 Years - Dartmouth-Hitchcock Medical Center View Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen NCT00016380 Cancer
dexamethasone
ondansetron
quality-of-life...
16 Years - 120 Years Canadian Cancer Trials Group View PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer NCT00055705 Cancer
PV701
18 Years - National Cancer Institute (NCI) View Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity NCT00003548 Cancer
aminocamptothec...
18 Years - NYU Langone Health View Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer NCT00096083 Cancer
isolated perfus...
melphalan
16 Years - Delcath Systems Inc. View Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction NCT00004911 Colorectal Canc...
Constipation, I...
Gastric Cancer
Gastrointestina...
Gastrointestina...
Quality of Life
Small Intestine...
bowel obstructi...
quality-of-life...
18 Years - Northwestern University View Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction NCT00004910 Colorectal Canc...
Constipation, I...
Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Gastrointestina...
Pancreatic Canc...
Quality of Life
Small Intestine...
bowel obstructi...
quality-of-life...
18 Years - Northwestern University View Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors NCT00084461 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Regional Gastro...
Somatostatinoma
romidepsin
laboratory biom...
18 Years - National Cancer Institute (NCI) View 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681 Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI) View